// App-Quantinova.ai

TCT-608 : Two-Year Outcomes after Implantation of XIENCE PRIME and XIENCE PRIME Long Lesion Stents in Patients with Coronary Artery Disease: Results of the SPIRIT PRIME Multicenter Pivotal Clinical Trial

Researchers

Presenter

  • Marco Costa

Principal Investigators

  • Dean Kereiakes

  • Robert Smith

  • Ken Wu

  • Xiaohe Yu

  • Louis Cannon

  • John Wang

  • Krishnankutty Sudhir

Medical Centers

  • McLaren Northern Michigan Hospital, Heart & Vascular Institute, Petoskey, Michigan

  • Medstar Union Memorial Hospital, Baltimore, MD

Locations

  • United States

Companies

  • Abbott

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Scavenger Receptor Class A Member 3

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved